Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Novo Nordisk (0QIU) Receives a Hold from Jefferies

Tipranks - Tipranks - Tue Apr 21, 7:38AM CDT

In a report released today, Michael Leuchten from Jefferies maintained a Hold rating on Novo Nordisk, with a price target of DKK270.00.

Claim 30% Off TipRanks

According to TipRanks, Leuchten is an analyst with an average return of -4.2% and a 51.95% success rate.

In a report released on April 17, Citi also maintained a Hold rating on the stock with a DKK275.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of DKK533.40 and a one-year low of DKK224.25. Currently, Novo Nordisk has an average volume of 8.39M.

Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of 0QIU in relation to earlier this year.

Read More on GB:0QIU:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).